Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer.

BACKGROUND Conditional cancer-specific survival rates account for changes in the risk of death from cancer over time. There may be a point during follow-up when patients who undergo lobectomy for stage I non-small cell lung cancer (NSCLC) are as likely to die of cardiovascular disease as of cancer. METHODS Using the Surveillance Epidemiology and End… CONTINUE READING